|
Age (Mean ± SD), years
|
65 ± 14
|
68 ± 14
|
64 ± 14
|
< 0.001a
|
|
Males, n (%)
|
1290 (63.1%)
|
113 (48.7%)
|
1177 (65.0%)
|
< 0.001b
|
|
Medical history, n (%)
|
|
Hypertension, n (%)
|
1132 (55.4%)
|
115 (49.5%)
|
1017 (56.2%)
|
0.864b
|
|
Diabetes mellitus, n (%)
|
467 (22.9%)
|
52 (22.4%)
|
415 (22.9%)
|
0.528b
|
|
Hyperlipidaemia, n (%)
|
75 (3.7%)
|
7 (3.0%)
|
68 (3.8%)
|
0.574b
|
|
Atrial fibrillation, n (%)
|
235 (11.5%)
|
69 (29.7%)
|
166 (9.2%)
|
< 0.001b
|
|
Smoking, n (%)
|
864 (42.3%)
|
83 (35.8%)
|
781 (43.1%)
|
0.033b
|
|
Alcohol consumption, n (%)
|
560 (27.4%)
|
51 (22.0%)
|
509 (28.1%)
|
0.049b
|
|
TOAST classification
|
|
Large-artery atherosclerosis, n (%)
|
671 (32.8%)
|
73 (31.5%)
|
598 (33.0%)
|
< 0.001b
|
|
Small-artery occlusion, n (%)
|
484 (23.7%)
|
4 (1.7%)
|
480 (26.5%)
| |
|
Cardioembolic, n (%)
|
434 (21.2%)
|
111 (47.8%)
|
323 (17.8%)
| |
|
Undetermined aetiology, n (%)
|
386 (18.9%)
|
40 (16.1%)
|
346 (19.3%)
| |
|
Other aetiology, n (%)
|
68 (3.3%)
|
4 (1.7%)
|
64 (3.5%)
| |
|
NIHSS on admission, median (IQR)
|
5 (2–10)
|
11(6–18)
|
5 (2–10)
|
< 0.001c
|
|
SBP, (Mean ± SD), mmHg
|
146 ± 23
|
140 ± 23
|
146 ± 23
|
< 0.001a
|
|
DBP, (Mean ± SD), mmHg
|
85 ± 15
|
84 ± 16
|
86 ± 15
|
0.048a
|
|
Glucose, (Mean ± SD), mmol/L
|
7.97 ± 3.45
|
8.16 ± 2.52
|
7.94 ± 3.55
|
0.233a
|
|
Thrombolysis, n (%)
|
107 (5.2%)
|
27 (11.6%)
|
80 (4.4%)
|
< 0.001b
|
|
Thrombectomy, n (%)
|
102 (5.0%)
|
24 (10.3%)
|
78 (4.3%)
|
< 0.001b
|
|
Lipid profile
|
|
TG, (Mean ± SD), mmol/L
|
1.68 ± 1.32
|
1.37 ± 1.01
|
1.72 ± 1.35
|
< 0.001a
|
|
TC, (Mean ± SD), mmol/L
|
4.38 ± 1.13
|
4.18 ± 1.11
|
4.41 ± 1.14
|
0.003a
|
|
HDL-C, (Mean ± SD), mmol/L
|
1.24 ± 0.37
|
1.32 ± 0.44
|
1.23 ± 0.36
|
0.005a
|
|
LDL-C, (Mean ± SD), mmol/L
|
2.64 ± 0.95
|
2.44 ± 0.86
|
2.66 ± 0.95
|
< 0.001a
|
|
Non-HDL-C, (Mean ± SD), mmol/L
|
3.14 ± 1.11
|
2.86 ± 1.05
|
3.18 ± 1.11
|
< 0.001a
|
